INS and diabetes mellitus: International guidelines recommend individualized SMBG frequency based on multiple factors, including type of diabetes, treatment regimen (i.e., lifestyle intervention, non-insulin oral and injectable agents, or insulin), quality of glycemic control, risk of hypoglycemia, and patient's willingness to self-test [4, 5].